A lower-middle market private equity investment firm based in New York City
Business Model:
Revenue: $10M
Employees: 51-200
Address: 120 Fifth Avenue
City: New York
State: NY
Zip: 10011
Country: US
Delos Capital is a lower-middle market private equity investment firm based in New York City. The Fund was formed in 2013 to invest in complex processes through Control Buyouts, Strategic Partnerships and Distressed Buyouts in companies with EBITDA of $10 – $30 million.
Contact Phone:
+12122574450
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
12/2022 | Rejoni | Series B | 0 |
7/2021 | Imperative Care | Series D | 0 |
5/2021 | Phanes Therapeutics | Series B | 0 |
12/2019 | Imperative Care | Series C | 0 |
2/2021 | Clover Biopharmaceuticals | Series C | 230M |
6/2023 | Eccogene | Series B | 0 |
5/2017 | Intrinsic Therapeutics | Debt Financing | 28M |
6/2016 | Allecra Therapeutics | Series B | 24.8M |
11/2019 | Clover Biopharmaceuticals | Series B | 43.2M |
11/2015 | BAROnova | Series D | 36.5M |
8/2015 | Syndax Pharmaceuticals | Series C | 0 |
5/2021 | LifeQ | Series A | 0 |
4/2019 | Intrinsic Therapeutics | Series E | 52M |
6/2019 | Viron | Series A | 25M |
11/2022 | Rgenta Therapeutics | Series A | 0 |
12/2021 | Viron | Series B | 50M |
9/2020 | Rejoni | Series A | 15M |
12/2021 | OncoMyx Therapeutics | Series B | 0 |
5/2018 | US Fitness Products | Private Equity Round | - |
12/2021 | OncoMyx Therapeutics | Series B | 0 |
12/2021 | Viron Inc. | Series B | 0 |
7/2021 | Imperative Care | Series D | 0 |
5/2021 | LifeQ | Series A | 0 |
5/2021 | Phanes Therapeutics | Series B | 0 |
2/2021 | Clover Biopharmaceuticals | Series C | 0 |
9/2020 | Rejoni | Series A | 0 |
12/2019 | Imperative Care | Series C | 0 |
11/2019 | Clover Biopharmaceuticals | Series B | 0 |
6/2019 | Viron Inc. | Series A | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|